MiR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo

Human Molecular Genetics

Volumn 24, Issue 23, 2015, Pages 6721-6735

  Smith, Pascal Y ^a,b   Hernandez Rapp, Julia ^a,b   Jolivette, Francis ^a,b   Lecours, Cynthia ^a,b   Bisht, Kanchan ^a,b   Goupil, Claudia ^a,b   Dorval, Veronique ^a,b   Parsi, Sepideh ^a,b   Morin, Françoise ^a,b   Planel, Emmanuel ^a,b   Bennett, David A ^c   Fernandez Gomez, Francisco Jose ^d,e   Sergeant, Nicolas ^d,e   Buée, Luc ^d,e   Tremblay, Marie Ève ^a,b   Calon, Frédéric ^a,b   Hébert, Sébastien S ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIV LILLE   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; MICRORNA; MICRORNA 132; MICRORNA 212; TAU PROTEIN; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, HUMAN; GSK3B PROTEIN, MOUSE; MIRN132 MICRORNA, HUMAN; MIRN132 MICRORNA, MOUSE; MIRN212 MICRORNA, HUMAN; MIRN212 MICRORNA, MOUSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BIOINFORMATICS; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; EPISODIC MEMORY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LONG TERM MEMORY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MOUSE; NONHUMAN; OSMOTIC PUMP; PERCEPTUAL SPEED; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING; WILD TYPE; WORKING MEMORY; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEINOSIS; TAUOPATHY;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMANS; MICE; MICRORNAS; PHOSPHORYLATION; PROTEIN AGGREGATION, PATHOLOGICAL; TAU PROTEINS; TAUOPATHIES;

EID: 84981727514     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv377     Document Type: Article

References (89)

1. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev., 33, 95-130.
2. Schraen-Maschke, S., Sergeant, N., Dhaenens, C.M., Bombois, S., Deramecourt, V., Caillet-Boudin, M.L., Pasquier, F., Maurage, C.A., Sablonniere, B., Vanmechelen, E. et al. (2008) Tau as a biomarker of neurodegenerative diseases. Biomark. Med., 2, 363-384.
3. Sergeant, N., Delacourte, A. and Buee, L. (2005) Tau protein as a differential biomarker of tauopathies. Biochimica et Biophysica Acta, 1739, 179-197.
4. Spillantini, M.G. and Goedert, M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci., 21, 428-433.
5. Tolnay, M. and Probst, A. (1999) Review: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol. Appl. Neurobiol., 25, 171-187.
6. Gallo, J.M., Noble, W. and Martin, T.R. (2007) RNA and proteindependent mechanisms in tauopathies: consequences for therapeutic strategies. Cell. Mol. Life Sci., 64, 1701-1714.
7. Liu, F. and Gong, C.X. (2008) Tau exon 10 alternative splicing and tauopathies. Mol. Neurodegener., 3, 8.
8. Hooli, B.V., Kovacs-Vajna, Z.M., Mullin, K., Blumenthal, M.A., Mattheisen, M., Zhang, C., Lange, C., Mohapatra, G., Bertram, L. and Tanzi, R.E. (2014) Rare autosomal copy number variations in early-onset familial Alzheimer's disease. Mol. Psychiatry, 19, 676-681.
9. Rovelet-Lecrux, A., Lecourtois, M., Thomas-Anterion, C., Le Ber, I., Brice, A., Frebourg, T., Hannequin, D. and Campion, D. (2009) Partial deletion of the MAPT gene: a novel mechanism of FTDP-17. Hum. Mutat., 30, E591-E602.
10. Rovelet-Lecrux, A. and Campion, D. (2012) Copy number variations involving the microtubule-associated protein tau in human diseases. Biochem. Soc. Trans., 40, 672-676.
11. Rovelet-Lecrux, A., Hannequin, D., Guillin, O., Legallic, S., Jurici, S., Wallon, D., Frebourg, T. and Campion, D. (2010) Frontotemporal dementia phenotype associated with MAPT gene duplication. J. Alzheimers Dis., 21, 897-902.
12. Myers, A.J., Kaleem, M., Marlowe, L., Pittman, A.M., Lees, A.J., Fung, H.C., Duckworth, J., Leung, D., Gibson, A., Morris, C.M. et al. (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum. Mol. Genet., 14, 2399-2404.
13. Allen, M., Kachadoorian, M., Quicksall, Z., Zou, F., Chai, H.S., Younkin, C., Crook, J.E., Pankratz, V.S., Carrasquillo, M.M., Krishnan, S. et al. (2014) Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. Alzheimers Res. Ther., 6, 39.
14. Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E. and Ambros, V. (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol., 5, R13.
15. Ziats, M.N. and Rennert, O.M. (2014) Identification of differentially expressed microRNAs across the developing human brain. Mol. Psychiatry, 19, 848-852.
16. Follert, P., Cremer, H. and Beclin, C. (2014) MicroRNAs in brain development and function: a matter of flexibility and stability. Front. Mol. Neurosci., 7, 5.
17. Dorval, V., Smith, P.Y., Delay, C., Calvo, E., Planel, E., Zommer, N., Buee, L. and Hebert, S.S. (2012) Gene network and pathway analysis of mice with conditional ablation of Dicer in postmitotic neurons. PloS one, 7, e44060.
18. Thomas, M., Lieberman, J. and Lal, A. (2010) Desperately seeking microRNA targets. Nat. Struct. Mol. Biol., 17, 1169-1174.
19. Vidigal, J.A. and Ventura, A. (2015) The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol., 25, 137-147.
20. Hebert, S.S., Papadopoulou, A.S., Smith, P., Galas, M.C., Planel, E., Silahtaroglu, A.N., Sergeant, N., Buee, L. and De Strooper, B. (2010) Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet., 19, 3959-3969.
21. Abe, M. and Bonini, N.M. (2013) MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol., 23, 30-36.
22. Delay, C., Dorval, V., Fok, A., Grenier-Boley, B., Lambert, J.C., Hsiung, G.Y. and Hebert, S.S. (2014) MicroRNAs targeting Nicastrin regulate Abeta production and are affected by target site polymorphisms. Front. Mol. Neurosci., 7, 67.
23. Hebert, S.S., Horre, K., Nicolai, L., Papadopoulou, A.S., Mandemakers, W., Silahtaroglu, A.N., Kauppinen, S., Delacourte, A. and De Strooper, B. (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl Acad. Sci. USA, 105, 6415-6420.
24. Hebert, S.S., Horre, K., Nicolai, L., Bergmans, B., Papadopoulou, A.S., Delacourte, A. and De Strooper, B. (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol. Dis., 33, 422-428.
25. Hebert, S.S. and De Strooper, B. (2007) Molecular biology. miRNAs in neurodegeneration. Science, 317, 1179-1180.
26. Delay, C., Mandemakers, W. and Hebert, S.S. (2012) Micro-RNAs in Alzheimer's disease. Neurobiol. Dis., 46, 285-290.
27. Wanet, A., Tacheny, A., Arnould, T. and Renard, P. (2012) miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucl. Acids Res., 40, 4742-4753.
28. Magill, S.T., Cambronne, X.A., Luikart, B.W., Lioy, D.T., Leighton, B.H., Westbrook, G.L., Mandel, G. and Goodman, R.H. (2010) microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc. Natl Acad. Sci. USA, 107, 20382-20387.
29. Vo, N., Klein, M.E., Varlamova, O., Keller, D.M., Yamamoto, T., Goodman, R.H. and Impey, S. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl Acad Sci. USA, 102, 16426-16431.
30. Remenyi, J., van den Bosch, M.W., Palygin, O., Mistry, R.B., McKenzie, C., Macdonald, A., Hutvagner, G., Arthur, J.S., Frenguelli, B.G. and Pankratov, Y. (2013) miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PloS One, 8, e62509.
31. Lambert, T.J., Storm, D.R. and Sullivan, J.M. (2010) Micro-RNA132 modulates short-term synaptic plasticity but not basal release probability in hippocampal neurons. PloS One, 5, e15182.
32. Wang, R.Y., Phang, R.Z., Hsu, P.H., Wang, W.H., Huang, H.T. and Liu, I.Y. (2013) In vivo knockdown of hippocampal miR-132 expression impairs memory acquisition of trace fear conditioning. Hippocampus, 23, 625-633.
33. Hernandez-Rapp, J., Smith, P.Y., Filali, M., Goupil, C., Planel, E., Magill, S.T., Goodman, R.H. and Hebert, S.S. (2015) Memory formation and retention are affected in adult miR-132/212 knockout mice. Behav. Brain Res., 287, 15-26.
34. Wong, H.K., Veremeyko, T., Patel, N., Lemere, C.A., Walsh, D. M., Esau, C., Vanderburg, C. and Krichevsky, A.M. (2013) De-repression of FOXO3a death axis by microRNA-132 and-212 causes neuronal apoptosis in Alzheimer's disease. Hum. Mol. Genet., 22, 3077-3092.
35. Hwang, J.Y., Kaneko, N., Noh, K.M., Pontarelli, F. and Zukin, R. S. (2014) The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die. J. Mol. Biol., 426, 3454-3466.
36. Hebert, S.S., Wang, W.X., Zhu, Q. and Nelson, P.T. (2013) A study of small RNAs from cerebral neocortex of pathologyverified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J. Alzheimers Dis., 35, 335-348.
37. Cogswell, J.P., Ward, J., Taylor, I.A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C. et al. (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis., 14, 27-41.
38. Wang, W.X., Huang, Q., Hu, Y., Stromberg, A.J. and Nelson, P.T. (2011) Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathologica, 121, 193-205.
39. Lau, P., Bossers, K., Janky, R., Salta, E., Frigerio, C.S., Barbash, S., Rothman, R., Sierksma, A.S., Thathiah, A., Greenberg, D. et al. (2013) Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol. Med., 5, 1613-1634.
40. Smith, P.Y., Delay, C., Girard, J., Papon, M.A., Planel, E., Sergeant, N., Buee, L. and Hebert, S.S. (2011) MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum. Mol. Genet., 20, 4016-4024.
41. Chen-Plotkin, A.S., Unger, T.L., Gallagher, M.D., Bill, E., Kwong, L.K., Volpicelli-Daley, L., Busch, J.I., Akle, S., Grossman, M., Van Deerlin, V. et al. (2012) TMEM106B, the risk gene for frontotemporal dementia, is regulated by the micro-RNA-132/212 cluster and affects progranulin pathways. J. Neurosci., 32, 11213-11227.
42. Planel, E., Xiaoyan, S. and Takashima, A. (2002) Role of GSK-3b in Alzheimer's disease pathology. Drug Develop.Res., 56, 491-510.
43. Papon, M.A., El Khoury, N.B., Marcouiller, F., Julien, C., Morin, F., Bretteville, A., Petry, F.R., Gaudreau, S., Amrani, A., Mathews, P.M. et al. (2013) Deregulation of protein phosphatase 2A and hyperphosphorylation of tau protein following onset of diabetes in NOD mice. Diabetes, 62, 609-617.
44. Planel, E., Miyasaka, T., Launey, T., Chui, D.H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y. and Takashima, A. (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J. Neurosci., 24, 2401-2411.
45. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and La-Ferla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 39, 409-421.
46. Duff, K., Knight, H., Refolo, L.M., Sanders, S., Yu, X., Picciano, M., Malester, B., Hutton, M., Adamson, J., Goedert, M. et al. (2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis., 7, 87-98.
47. Jicha, G.A., Bowser, R., Kazam, I.G. and Davies, P. (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res., 48, 128-132.
48. Weaver, C.L., Espinoza, M., Kress, Y. and Davies, P. (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging, 21, 719-727.
49. Ambegaokar, S.S. and Jackson, G.R. (2012) The downward spiral of tau and autolysosomes: a new hypothesis in neurodegeneration. Autophagy, 8, 1144-1145.
50. Caccamo, A., Magri, A., Medina, D.X., Wisely, E.V., Lopez-Aranda, M.F., Silva, A.J. and Oddo, S. (2013) mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell, 12, 370-380.
51. Jo, C., Gundemir, S., Pritchard, S., Jin, Y.N., Rahman, I. and Johnson, G.V. (2014) Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat. Commun., 5, 3496.
52. Ozcelik, S., Fraser, G., Castets, P., Schaeffer, V., Skachokova, Z., Breu, K., Clavaguera, F., Sinnreich, M., Kappos, L., Goedert, M. et al. (2013) Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PloS One, 8, e62459.
53. Ucar, A., Gupta, S.K., Fiedler, J., Erikci, E., Kardasinski, M., Batkai, S., Dangwal, S., Kumarswamy, R., Bang, C., Holzmann, A. et al. (2012) The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun., 3, 1078.
54. Koval, E.D., Shaner, C., Zhang, P., du Maine, X., Fischer, K., Tay, J., Chau, B.N., Wu, G.F. and Miller, T.M. (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet., 22, 4127-4135.
55. Sheinerman, K.S., Tsivinsky, V.G., Abdullah, L., Crawford, F. and Umansky, S.R. (2013) Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging, 5, 925-938.
56. Sheinerman, K.S., Tsivinsky, V.G., Crawford, F., Mullan, M.J., Abdullah, L. and Umansky, S.R. (2012) Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging, 4, 590-605.
57. Tremblay, C., Pilote, M., Phivilay, A., Emond, V., Bennett, D.A. and Calon, F. (2007) Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis., 12, 377-390.
58. Julien, C., Tremblay, C., Bendjelloul, F., Phivilay, A., Coulombe, M.A., Emond, V. and Calon, F. (2008) Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology. J. Neurosci. Res., 86, 2292-2302.
59. Dickson, J.R., Kruse, C., Montagna, D.R., Finsen, B. andWolfe, M.S. (2013) Alternative polyadenylation and miR-34 family members regulate tau expression. J. Neurochem., 127, 739-749.
60. Chi, S.W., Zang, J.B., Mele, A. and Darnell, R.B. (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature, 460, 479-486.
61. Gotz, J. and Ittner, L.M. (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci., 9, 532-544.
62. Peric, A. and Annaert, W. (2015) Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction? Acta Neuropathologica, 129, 363-381.
63. Perluigi, M., Di Domenico, F. and Butterfield, D.A. (2015)mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol. Dis., in press.
64. Nixon, R.A. (2013) The role of autophagy in neurodegenerative disease. Nat. Med., 19, 983-997.
65. Hardy, J. and Rogaeva, E. (2014) Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not. Exp. Neurol., 262(Pt B), 75-83.
66. de Calignon, A., Polydoro, M., Suarez-Calvet, M., William, C., Adamowicz, D.H., Kopeikina, K.J., Pitstick, R., Sahara, N., Ashe, K.H., Carlson, G.A. et al. (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron, 73, 685-697.
67. Baglietto-Vargas, D., Kitazawa, M., Le, E.J., Estrada-Hernandez, T., Rodriguez-Ortiz, C.J., Medeiros, R., Green, K.N. and LaFerla, F.M. (2014) Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition. Neurobiol. Dis., 62, 407-415.
68. Stancu, I.C., Vasconcelos, B., Terwel, D. and Dewachter, I. (2014) Models of beta-amyloid induced Tau-pathology: the long and 'folded' road to understand the mechanism. Mol. Neurodegenerat., 9, 51.
69. Shaked, I., Meerson, A., Wolf, Y., Avni, R., Greenberg, D., Gilboa-Geffen, A. and Soreq, H. (2009) MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity, 31, 965-973.
70. Schliebs, R. and Arendt, T. (2011) The cholinergic system in aging and neuronal degeneration. Behav. Brain Res., 221, 555-563.
71. Girao da Cruz, M.T., Jordao, J., Dasilva, K.A., Ayala-Grosso, C. A., Ypsilanti, A., Weng, Y.Q., Laferla, F.M., McLaurin, J. and Aubert, I. (2012) Early increases in soluble amyloid-beta levels coincide with cholinergic degeneration in 3xTg-AD mice. J. Alzheimers Dis., 32, 267-272.
72. Wang, X., Tan, L., Lu, Y., Peng, J., Zhu, Y., Zhang, Y. and Sun, Z. (2015) MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha. FEBS Lett., 589, 726-729.
73. Banzhaf-Strathmann, J., Benito, E., May, S., Arzberger, T., Tahirovic, S., Kretzschmar, H., Fischer, A. and Edbauer, D. (2014) MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease. EMBO J., 33, 1667-1680.
74. Zhao, Z.B., Wu, L., Xiong, R., Wang, L.L., Zhang, B., Wang, C., Li, H., Liang, L. and Chen, S.D. (2014) MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxyterminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease. Neuroscience, 275, 232-237.
75. Santa-Maria, I., Alaniz, M.E., Renwick, N., Cela, C., Fulga, T.A., Van Vactor, D., Tuschl, T., Clark, L.N., Shelanski, M.L., McCabe, B.D. et al. (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J. Clin. Investig., 125, 681-686.
76. Dugas, J.C., Cuellar, T.L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J.L., Foo, L.C., McManus, M.T. and Barres, B.A. (2010) Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation andmyelination. Neuron, 65, 597-611.
77. Wayman, G.A., Davare, M., Ando, H., Fortin, D., Varlamova, O., Cheng, H.Y., Marks, D., Obrietan, K., Soderling, T.R., Goodman, R.H. et al. (2008) An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl Acad. Sci. USA, 105, 9093-9098.
78. Kawashima, H., Numakawa, T., Kumamaru, E., Adachi, N., Mizuno, H., Ninomiya, M., Kunugi, H. and Hashido, K. (2010) Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience, 165, 1301-1311.
79. Remenyi, J., Hunter, C.J., Cole, C., Ando, H., Impey, S., Monk, C. E., Martin, K.J., Barton, G.J., Hutvagner, G. and Arthur, J.S. (2010) Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem. J., 428, 281-291.
80. Lee, S.T., Chu, K., Im, W.S., Yoon, H.J., Im, J.Y., Park, J.E., Park, K.H., Jung, K.H., Lee, S.K., Kim, M. et al. (2011) Altered micro-RNA regulation in Huntington's disease models. Exp. Neurol., 227, 172-179.
81. Miller, B.H., Zeier, Z., Xi, L., Lanz, T.A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P.J., Elsworth, J.D., Lawrence, M.S. et al. (2012) MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc. Natl Acad. Sci. USA, 109, 3125-3130.
82. Freischmidt, A., Muller, K., Ludolph, A.C. andWeishaupt, J.H. (2013) Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathologica Commun., 1, 42.
83. Casanova, M.F., Stevens, J.R., Brown, R., Royston, C. and Bruton, C. (2002) Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathologica, 103, 313-320.
84. Fernandez-Nogales, M., Cabrera, J.R., Santos-Galindo, M., Hoozemans, J.J., Ferrer, I., Rozemuller, A.J., Hernandez, F., Avila, J. and Lucas, J.J. (2014) Huntington's disease is a fourrepeat tauopathy with tau nuclear rods. Nat.Med., 20, 881-885.
85. Wilson, R.S., Barnes, L.L., Mendes de Leon, C.F., Aggarwal, N. T., Schneider, J.S., Bach, J., Pilat, J., Beckett, L.A., Arnold, S.E., Evans, D.A. et al. (2002) Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology, 59, 364-370.
86. Ohta, Y., Tremblay, C., Schneider, J.A., Bennett, D.A., Calon, F. and Julien, J.P. (2014) Interaction of transactive response DNA binding protein 43 with nuclear factor kappaB in mild cognitive impairment with episodic memory deficits. Acta Neuropathologica Commun., 2, 37.
87. Otvos, L. Jr, Feiner, L., Lang, E., Szendrei, G.I., Goedert, M. and Lee, V.M. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res., 39, 669-673.
88. Tremblay, M.E., Riad, M. and Majewska, A. (2010) Preparation of mouse brain tissue for immunoelectron microscopy. J. Visual. Exp., 41, 1-5.
89. Paxinos, G. and Franklin, K.B. (2013) The Mouse Brain in Stereotaxic Coordinates. Academic Press, New York.